{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:15:46Z","timestamp":1791814546475,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40123-025-01279-9","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:58:20Z","timestamp":1764586700000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Significant Correlation Between Choroidal Thickness and Decrease in Choroidal Blood Flow After Switching to Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration"],"prefix":"10.1007","volume":"15","author":[{"given":"Hirokazu","family":"Kojima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Booka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tatara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeyasu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Akimitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Suzuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"1279_CR1","first-page":"182","volume":"36","author":"R Klein","year":"1995","unstructured":"Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1279_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"1279_CR3","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221\u201334.","journal-title":"Lancet Glob Health"},{"key":"1279_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ophtha.2019.12.031","volume":"127","author":"QD Nguyen","year":"2020","unstructured":"Nguyen QD, Das A, Do DV, et al. Brolucizumab: Evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration. Ophthalmology. 2020;127:963\u201376.","journal-title":"Ophthalmology"},{"key":"1279_CR5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ophtha.2015.12.030","volume":"123","author":"FG Holz","year":"2016","unstructured":"Holz FG, Dugel PU, Weissgerber G, et al. Single-chain antibody fragment VEGF inhibitor RTH258 for neovascular age-related macular degeneration: a randomized controlled study. Ophthalmology. 2016;123:1080\u20139.","journal-title":"Ophthalmology"},{"key":"1279_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","volume":"128","author":"PU Dugel","year":"2021","unstructured":"Dugel PU, Singh RP, Koh A, et al. HAWK and HARRIER: ninety-six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 2021;128:89\u201399.","journal-title":"Ophthalmology"},{"key":"1279_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","volume":"127","author":"PU Dugel","year":"2020","unstructured":"Dugel PU, Koh A, Ogura Y, et al. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 2020;127:72\u201384.","journal-title":"Ophthalmology"},{"key":"1279_CR8","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/JCI119868","volume":"100","author":"A Papapetropoulos","year":"1997","unstructured":"Papapetropoulos A, Garc\u00eda-Carde\u00f1a G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100:3131\u20139.","journal-title":"J Clin Invest"},{"key":"1279_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10792-024-03107-8","volume":"44","author":"H Takizawa","year":"2024","unstructured":"Takizawa H, Yasuda M, Hoshi K, Okabe T, Kunikata H, Nakazawa T. Changes in ocular blood flow in patients with neovascular age-related macular degeneration after intravitreal injection of ranibizumab biosimilar and brolucizumab. Int Ophthalmol. 2024;44:181.","journal-title":"Int Ophthalmol"},{"key":"1279_CR10","first-page":"1706","volume":"27","author":"CE Riva","year":"1986","unstructured":"Riva CE, Grunwald JE, Petrig BL. Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci. 1986;27:1706\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1279_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1755-3768.2009.01586.x","volume":"88","author":"T Sugiyama","year":"2010","unstructured":"Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S. Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol. 2010;88:723\u20139.","journal-title":"Acta Ophthalmol"},{"key":"1279_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0014-4835(05)80094-6","volume":"60","author":"Y Tamaki","year":"1995","unstructured":"Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii H. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp Eye Res. 1995;60:373\u201383.","journal-title":"Exp Eye Res"},{"key":"1279_CR13","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.11.4","volume":"9","author":"M Matsumoto","year":"2020","unstructured":"Matsumoto M, Suzuma K, Akiyama F, et al. Retinal microvascular resistance estimated from waveform analysis is significantly higher with a threshold value in central retinal vein occlusion. Transl Vis Sci Technol. 2020;9:4.","journal-title":"Transl Vis Sci Technol"},{"key":"1279_CR14","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.11.19","volume":"10","author":"M Matsumoto","year":"2021","unstructured":"Matsumoto M, Suzuma K, Akiyama F, et al. Retinal vascular resistance significantly correlates with visual acuity after 1 year of anti-VEGF therapy in central retinal vein occlusion. Transl Vis Sci Technol. 2021;10:19.","journal-title":"Transl Vis Sci Technol"},{"key":"1279_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/IAE.0000000000001531","volume":"38","author":"M Matsumoto","year":"2018","unstructured":"Matsumoto M, Suzuma K, Yamada Y, Tsuiki E, Fujikawa A, Kitaoka T. Retinal blood flow after intravitreal bevacizumab is a predictive factor for outcomes of macular edema associated with central retinal vein occlusion. Retina. 2018;38:283\u201391.","journal-title":"Retina"},{"key":"1279_CR16","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2147\/OPTH.S168420","volume":"12","author":"E Tsuiki","year":"2018","unstructured":"Tsuiki E, Suzuma K, Matsumoto M, Mohamed YH, Kitaoka T. Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema. Clin Ophthalmol. 2018;12:1845\u201352.","journal-title":"Clin Ophthalmol"},{"key":"1279_CR17","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1167\/iovs.14-14447","volume":"55","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, et al. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest Ophthalmol Vis Sci. 2014;55:3893\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1279_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204183","volume":"13","author":"H Kojima","year":"2018","unstructured":"Kojima H, Hirooka K, Nitta E, Sonoda S, Sakamoto T. Peripapillary and macular choroidal area in patients with normal-tension glaucoma. PLoS ONE. 2018;13:e0204183.","journal-title":"PLoS ONE"},{"key":"1279_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/11206721231187663","volume":"34","author":"A Chronopoulos","year":"2024","unstructured":"Chronopoulos A, Huynh E, Ashurov A, Schutz JS, Jonas JB, Hattenbach LO. Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment. Eur J Ophthalmol. 2024;34:487\u201396.","journal-title":"Eur J Ophthalmol"},{"key":"1279_CR20","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1038\/s41598-022-23392-6","volume":"12","author":"KW Bae","year":"2022","unstructured":"Bae KW, Kim DI, Hwang DD. The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration. Sci Rep. 2022;12:19855.","journal-title":"Sci Rep"},{"key":"1279_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10384-022-00908-1","volume":"66","author":"H Ota","year":"2022","unstructured":"Ota H, Takeuchi J, Nakano Y, et al. Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration. Jpn J Ophthalmol. 2022;66:278\u201384.","journal-title":"Jpn J Ophthalmol"},{"key":"1279_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195517","volume":"11","author":"P Viggiano","year":"2022","unstructured":"Viggiano P, Grassi MO, Boscia G, et al. Short-term morphofunctional changes in previously treated neovascular AMD eyes switched to brolucizumab. J Clin Med. 2022;11:5517.","journal-title":"J Clin Med"},{"key":"1279_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10384-022-00940-1","volume":"66","author":"Y Kitajima","year":"2022","unstructured":"Kitajima Y, Maruyama-Inoue M, Ikeda S, et al. Short-term outcomes of switching to brolucizumab in Japanese patients with neovascular age-related macular degeneration. Jpn J Ophthalmol. 2022;66:511\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"1279_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154375","volume":"13","author":"K Hirayama","year":"2024","unstructured":"Hirayama K, Yamamoto M, Honda S, Kyo A, Misawa N, Kohno T. Switching to intravitreal brolucizumab after ranibizumab or aflibercept using treat and extend regimen for neovascular age-related macular degeneration in Japanese patients: 1-year results and factors associated with treatment responsiveness. J Clin Med. 2024;13:4375.","journal-title":"J Clin Med"},{"key":"1279_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040562","volume":"16","author":"W Kikushima","year":"2023","unstructured":"Kikushima W, Sakurada Y, Fukuda Y, et al. A treat-and-extend regimen of intravitreal brolucizumab for exudative age-related macular degeneration refractory to aflibercept: a 12-month result. Pharmaceuticals (Basel). 2023;16:562.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1279_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1159\/000534894","volume":"66","author":"ML Ruggeri","year":"2023","unstructured":"Ruggeri ML, Toto L, D\u2019Aloisio R, et al. Long-term follow-up of brolucizumab in macular neovascularization. Ophthalmic Res. 2023;66:1383\u201391.","journal-title":"Ophthalmic Res"},{"key":"1279_CR27","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1038\/s41598-023-30146-5","volume":"13","author":"H Matsumoto","year":"2023","unstructured":"Matsumoto H, Hoshino J, Nakamura K, Akiyama H. Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-na\u00efve neovascular age-related macular degeneration with type 1 macular neovascularization. Sci Rep. 2023;13:3249.","journal-title":"Sci Rep"},{"key":"1279_CR28","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1038\/s41598-022-10578-1","volume":"12","author":"H Matsumoto","year":"2022","unstructured":"Matsumoto H, Hoshino J, Mukai R, Nakamura K, Akiyama H. One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-na\u00efve neovascular age-related macular degeneration with type 1 macular neovascularization. Sci Rep. 2022;12:8195.","journal-title":"Sci Rep"},{"key":"1279_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52315-w","volume":"14","author":"G Boscia","year":"2024","unstructured":"Boscia G, Pozharitskiy N, Grassi MO, Borrelli E, et al. Choroidal remodeling following different anti-VEGF therapies in neovascular AMD. Sci Rep. 2024;14:1941.","journal-title":"Sci Rep"},{"key":"1279_CR30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41433-022-02091-6","volume":"37","author":"L Toto","year":"2023","unstructured":"Toto L, Ruggeri ML, Evangelista F, et al. Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy. Eye (Lond). 2023;37:1214\u20138.","journal-title":"Eye (Lond)"},{"key":"1279_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/bjophthalmol-2019-313919","volume":"104","author":"AS Mursch-Edlmayr","year":"2020","unstructured":"Mursch-Edlmayr AS, Luft N, Podkowinski D, Ring M, Schmetterer L, Bolz M. Effects of three intravitreal injections of aflibercept on the ocular circulation in eyes with age-related maculopathy. Br J Ophthalmol. 2020;104:53\u20137.","journal-title":"Br J Ophthalmol"},{"key":"1279_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ajo.2008.12.008","volume":"147","author":"R Margolis","year":"2009","unstructured":"Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811\u20135.","journal-title":"Am J Ophthalmol"},{"key":"1279_CR33","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ophtha.2020.03.031","volume":"127","author":"SR Sadda","year":"2020","unstructured":"Sadda SR, Abdelfattah NS, Lei J, et al. Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration. Ophthalmology. 2020;127:1360\u201370.","journal-title":"Ophthalmology"},{"key":"1279_CR34","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00417-021-05517-1","volume":"260","author":"T Tamashiro","year":"2022","unstructured":"Tamashiro T, Tanaka K, Itagaki K, et al. Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study. Graefes Arch Clin Exp Ophthalmol. 2022;260:1857\u201365.","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01279-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:32:59Z","timestamp":1770453179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01279-9","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hirokazu Kojima, Ayana Yamashita, Yuki Nakano, Aki Booka, Yusuke Tatara, Takeyasu Yamada, Junichiro Akimitsu, Yukiko Miyoshi, Rie Osaka, and Kiyoshi Suzuma declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The patients provided written informed consent for participation in this study. This study protocol was reviewed and approved by the Kagawa University Faculty of Medicine Ethics Committee (approval number: 2020\u2013062).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}